中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
21期
48-50
,共3页
包裹性胸腔积液%胸腔置管引流%尿激酶%联合疗法
包裹性胸腔積液%胸腔置管引流%尿激酶%聯閤療法
포과성흉강적액%흉강치관인류%뇨격매%연합요법
Encapsulated pleural effusion%Thoracic drainage with tube%Urokinase%Combined treatment
目的：探讨胸腔置管引流联合腔内注射尿激酶治疗在包裹性胸腔积液的临床应用价值。方法：将100例胸腔积液患者按随机数字表法分为研究组和对照组，每组50例。研究组给予胸腔置管引流联合腔内注射尿激酶治疗，对照组给予常规反复胸腔穿刺抽液治疗，比较两组在疗效、住院天数和治疗费用等方面的差异。结果：研究组治疗有效率为96.0%，高于对照组的82.0%（χ2=5.005，P=0.025）；研究组疗效也高于对照组，差异有统计学意义（Z=2.842，P=0.004）；研究组胸腔积液消失时间短于对照组，肺功能中FEV1%和FVC%均高于对照组，住院时间短于对照组，差异均有统计学意义（P<0.05）；两组的住院费用比较差异无统计学意义（P>0.05）。结论：胸腔置管引流联合腔内注射尿激酶是一种安全简便、疗效好、适合基层医院应用的治疗包裹性胸腔积液的方法。
目的：探討胸腔置管引流聯閤腔內註射尿激酶治療在包裹性胸腔積液的臨床應用價值。方法：將100例胸腔積液患者按隨機數字錶法分為研究組和對照組，每組50例。研究組給予胸腔置管引流聯閤腔內註射尿激酶治療，對照組給予常規反複胸腔穿刺抽液治療，比較兩組在療效、住院天數和治療費用等方麵的差異。結果：研究組治療有效率為96.0%，高于對照組的82.0%（χ2=5.005，P=0.025）；研究組療效也高于對照組，差異有統計學意義（Z=2.842，P=0.004）；研究組胸腔積液消失時間短于對照組，肺功能中FEV1%和FVC%均高于對照組，住院時間短于對照組，差異均有統計學意義（P<0.05）；兩組的住院費用比較差異無統計學意義（P>0.05）。結論：胸腔置管引流聯閤腔內註射尿激酶是一種安全簡便、療效好、適閤基層醫院應用的治療包裹性胸腔積液的方法。
목적：탐토흉강치관인류연합강내주사뇨격매치료재포과성흉강적액적림상응용개치。방법：장100례흉강적액환자안수궤수자표법분위연구조화대조조，매조50례。연구조급여흉강치관인류연합강내주사뇨격매치료，대조조급여상규반복흉강천자추액치료，비교량조재료효、주원천수화치료비용등방면적차이。결과：연구조치료유효솔위96.0%，고우대조조적82.0%（χ2=5.005，P=0.025）；연구조료효야고우대조조，차이유통계학의의（Z=2.842，P=0.004）；연구조흉강적액소실시간단우대조조，폐공능중FEV1%화FVC%균고우대조조，주원시간단우대조조，차이균유통계학의의（P<0.05）；량조적주원비용비교차이무통계학의의（P>0.05）。결론：흉강치관인류연합강내주사뇨격매시일충안전간편、료효호、괄합기층의원응용적치료포과성흉강적액적방법。
To investigate clinical application value of intracavitary urokinase injection combined with thoracic drainage by tube.Method:100 patients of pleural effusion were divided into the study group(n=50)and the control group(n=50). Intracavitary urokinase injection combined with thoracic drainage by tube were adopted in the study group. While routinely repeated thoracentesis treatment was used to draw the pleural effusion in the control group. The two groups’difference on curative effect,hospital day ,treatment costs and so on were analyzed.Result:The effective rate of the study group was 96.0%,and was higher than the control group’s 82.0%( χ2=5.005,P=0.025),the team effectiveness was higher than the control group,the difference was statistically significant(Z=2.842,P=0.004). In the study group,pulmonary function included FEV1%and FVC%were higher than that in the control group,the vanish time of pleural effusion was shorter than that in the control group,the hospital day was shorter than that in the control group,the differences were statistically significant(P<0.05). And there was no difference in cost of hospitalization between the two groups(P>0.05).Conclusion:Intracavitary urokinase injection combined with thoracic drainage by tube is a treatment of safety,convenience,nice curative effect and so on. So it is a good method suited for the primary hospitals to apply.
